Liposomal cytarabine
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Liposomal cytarabine, covering 2012-10-10 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia [Phase 1]